These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30085157)

  • 21. DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
    Mohamed Yoosuf AB; AlShehri S; Alhadab A; Alqathami M
    J Appl Clin Med Phys; 2019 Nov; 20(11):80-87. PubMed ID: 31605456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMRT QA: Selecting gamma criteria based on error detection sensitivity.
    Steers JM; Fraass BA
    Med Phys; 2016 Apr; 43(4):1982. PubMed ID: 27036593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment patient-specific quality assurance prediction based on 1D complexity metrics and 3D planning dose: classification, gamma passing rates, and DVH metrics.
    Chen L; Luo H; Li S; Tan X; Feng B; Yang X; Wang Y; Jin F
    Radiat Oncol; 2023 Nov; 18(1):192. PubMed ID: 37986008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the sensitivity of two 3D diode array dosimetry systems to setup error for quality assurance (QA) of volumetric-modulated arc therapy (VMAT).
    Li G; Bai S; Chen N; Henderson L; Wu K; Xiao J; Zhang Y; Jiang Q; Jiang X
    J Appl Clin Med Phys; 2013 Sep; 14(5):13-24. PubMed ID: 24036856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans.
    McKenzie EM; Balter PA; Stingo FC; Jones J; Followill DS; Kry SF
    Med Phys; 2014 Dec; 41(12):121702. PubMed ID: 25471949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
    Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
    J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility in patient-specific IMRT QA.
    McKenzie EM; Balter PA; Stingo FC; Jones J; Followill DS; Kry SF
    J Appl Clin Med Phys; 2014 May; 15(3):4741. PubMed ID: 24892350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.
    Chan MF; Li J; Schupak K; Burman C
    Technol Cancer Res Treat; 2014 Feb; 13(1):57-67. PubMed ID: 23819494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On using 3D γ-analysis for IMRT and VMAT pretreatment plan QA.
    Wu C; Hosier KE; Beck KE; Radevic MB; Lehmann J; Zhang HH; Kroner A; Dutton SC; Rosenthal SA; Bareng JK; Logsdon MD; Asche DR
    Med Phys; 2012 Jun; 39(6):3051-9. PubMed ID: 22755690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Institutional patient-specific IMRT QA does not predict unacceptable plan delivery.
    Kry SF; Molineu A; Kerns JR; Faught AM; Huang JY; Pulliam KB; Tonigan J; Alvarez P; Stingo F; Followill DS
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1195-201. PubMed ID: 25442044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial clinical experience with ArcCHECK for IMRT/VMAT QA.
    Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK
    J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.
    Lin MH; Koren S; Veltchev I; Li J; Wang L; Price RA; Ma CM
    J Appl Clin Med Phys; 2013 May; 14(2):3929. PubMed ID: 23470927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating AAPM-TG-218 recommendations: Gamma index tolerance and action limits in IMRT and VMAT quality assurance using SunCHECK.
    Deng J; Liu S; Huang Y; Li X; Wu X
    J Appl Clin Med Phys; 2024 Jun; 25(6):e14277. PubMed ID: 38243604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of DVH-based treatment plan verification in addition to gamma passing rates for head and neck IMRT.
    Visser R; Wauben DJ; de Groot M; Steenbakkers RJ; Bijl HP; Godart J; van't Veld AA; Langendijk JA; Korevaar EW
    Radiother Oncol; 2014 Sep; 112(3):389-95. PubMed ID: 25154319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the Region for Evaluation of Global Gamma Analysis for Nasopharyngeal Cancer (NPC) Pretreatment IMRT QA by COMPASS: A Retrospective Study.
    Lu W; Li Y; Huang W; Cui H; Zhang H; Yi X
    Front Oncol; 2022; 12():859415. PubMed ID: 35774127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
    Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
    Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating IMRT and VMAT dose accuracy: practical examples of failure to detect systematic errors when applying a commonly used metric and action levels.
    Nelms BE; Chan MF; Jarry G; Lemire M; Lowden J; Hampton C; Feygelman V
    Med Phys; 2013 Nov; 40(11):111722. PubMed ID: 24320430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
    Li G; Wu K; Peng G; Zhang Y; Bai S
    Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the modulation degrees of intensity-modulated radiation therapy plans.
    Park SY; Kim JI; Chun M; Ahn H; Park JM
    Radiat Oncol; 2018 Dec; 13(1):244. PubMed ID: 30545396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To propose adding index of achievement (IOA) to IMRT QA process.
    Kim DS; Kim S; Kang SH; Kim TH; Park SH; Kim KH; Cho MS; Shin DS; Noh YY; Chung JB; Suh TS
    Radiat Oncol; 2018 Jun; 13(1):112. PubMed ID: 29903025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.